Jazz Pharmaceuticals PLC (JAZZ)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 84.57% | 77.79% | 77.56% | 81.53% | 84.69% | 86.94% | 85.99% | 85.18% | 85.23% | 85.79% | 85.04% | 84.37% | 85.76% | 87.61% | 90.42% | 93.41% | 93.70% | 94.12% | 94.43% | 94.38% |
| Operating profit margin | 17.86% | 18.49% | 16.63% | 15.83% | 17.17% | 14.96% | 14.72% | 12.88% | 12.11% | 10.63% | 7.21% | 2.90% | 5.50% | 10.28% | 17.60% | 29.96% | 16.00% | 11.66% | 9.15% | 9.55% |
| Pretax margin | 11.56% | 9.98% | 7.61% | 6.28% | 7.77% | -2.73% | -7.00% | -8.67% | -10.19% | -2.17% | -2.45% | -7.34% | -3.65% | 2.68% | 11.90% | 25.45% | 11.64% | 7.50% | 5.28% | 5.93% |
| Net profit margin | 13.77% | 11.60% | 10.10% | 8.61% | 10.82% | 2.13% | -2.21% | -4.09% | -5.92% | -0.33% | -1.37% | -13.50% | -10.65% | -5.62% | 1.53% | 21.27% | 10.10% | 7.86% | 6.01% | 12.81% |
Based on the provided data, Jazz Pharmaceuticals PLC's profitability ratios have shown some fluctuations over the specified time periods.
1. Gross Profit Margin: The gross profit margin of Jazz Pharmaceuticals PLC has been relatively high, ranging from around 85% to 94% from March 31, 2020, to December 31, 2024. There has been a gradual decline in the gross profit margin over the years, with a significant drop from 90.42% as of June 30, 2021, to 77.56% by June 30, 2024.
2. Operating Profit Margin: The operating profit margin has exhibited variability over the years, with fluctuations in profitability. The margin started at 9.55% on March 31, 2020, increased significantly to 29.96% by March 31, 2021, and ranged between 15.83% and 18.49% from March 31, 2024, to September 30, 2024.
3. Pre-Tax Margin: The pre-tax margin of Jazz Pharmaceuticals PLC has been volatile, moving from positive to negative figures over the observed periods. From March 31, 2020, to December 31, 2024, the pre-tax margin ranged from -10.19% to 25.45%, indicating fluctuations in the company's profitability levels.
4. Net Profit Margin: Similarly, the net profit margin of the company has shown fluctuating trends. It ranged from -13.50% to 21.27% from March 31, 2022, to March 31, 2021. The margins were negative in some periods, indicating that the company incurred losses during those times.
Overall, Jazz Pharmaceuticals PLC's profitability ratios demonstrate fluctuations in profitability over the observed time frame, with an overall trend of decreasing profitability margins in recent periods. It is essential for the company to effectively manage costs and improve operational efficiency to enhance its profit margins in the future.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 6.05% | 6.02% | 5.72% | 5.37% | 5.78% | 5.07% | 4.92% | 4.36% | 4.09% | 3.67% | 2.24% | 0.81% | 1.38% | 2.36% | 3.50% | 10.80% | 5.78% | 4.23% | 3.34% | 4.01% |
| Return on assets (ROA) | 4.66% | 3.78% | 3.48% | 2.92% | 3.64% | 0.72% | -0.74% | -1.38% | -2.00% | -0.12% | -0.43% | -3.79% | -2.68% | -1.29% | 0.30% | 7.67% | 3.65% | 2.85% | 2.20% | 5.38% |
| Return on total capital | 18.30% | 18.39% | 18.05% | 17.24% | 19.26% | 18.03% | 17.16% | 18.24% | 18.85% | 29.98% | 21.97% | 13.16% | 12.00% | 8.56% | 12.46% | 20.75% | 11.89% | 8.49% | 8.45% | 9.59% |
| Return on equity (ROE) | 13.68% | 11.10% | 10.50% | 8.95% | 11.10% | 2.31% | -2.36% | -4.59% | -7.02% | -0.44% | -1.49% | -12.35% | -8.31% | -4.09% | 0.97% | 13.65% | 6.52% | 5.31% | 4.24% | 9.98% |
Jazz Pharmaceuticals PLC's profitability ratios exhibit fluctuating trends over the analyzed periods. The Operating Return on Assets (Operating ROA) ranged from a low of 0.81% on March 31, 2022, to a peak of 10.80% on March 31, 2021. The ROA shows a similar trend, with the lowest value recorded at -3.79% on March 31, 2022, and the highest at 7.67% on March 31, 2021.
In terms of Return on Total Capital, Jazz Pharmaceuticals displayed a pattern of volatility, with the ratio reaching a high of 29.98% on September 30, 2022, and a low of 8.45% on June 30, 2020. Return on Equity (ROE) varied from a low of -12.35% on March 31, 2022, to a high of 13.68% on December 31, 2024.
Overall, Jazz Pharmaceuticals PLC's profitability ratios indicate fluctuations in performance, with both positive and negative trends observed across the different metrics analyzed. Additional analysis incorporating industry benchmarks and qualitative factors would provide further insights into the company's financial health and operational efficiency.